Paroxetine Tablet, Film Coated
Product Images NDC 68382-001

8 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68382-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 01)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 01)
Chemical structure of Paroxetine hydrochloride, shown with its characteristic fluorophenyl, piperidine, and dioxolane ring components.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 02)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 02)
A clinical pharmacokinetic interaction chart showing fold change and 90% confidence intervals for the drugs Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The chart plots change relative to reference on a logarithmic scale comparing Cmax and AUC values for each drug interaction.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 03)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 03)
A scatter plot chart showing fold change and 90% confidence intervals for Cmax and AUC pharmacokinetic (PK) parameters of Paroxetine when taken with interacting drugs (Cimetidine, Phenobarbital, Phenytoin, Digoxin, Diazepam). The x-axis represents change relative to reference, ranging from 0 to 2, and each interacting drug has paired points for Cmax and AUC with corresponding confidence intervals.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 04)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 04)
A plot showing pharmacokinetic (PK) parameters, specifically fold change and 90% confidence intervals for Cmax, Cmin, and AUC, across different population subgroups. Subgroups include renal impairment severity (mild, moderate, severe), hepatic impairment, age over 65 with varying doses, and gender (males). The x-axis indicates change relative to reference with a logarithmic scale from 0.5 to 50.*
FDA Label Image

10 mg 500s Count (3dbda37c 9453 474f A247 Fceb50497ae8 05)

10 mg 500s Count (3dbda37c 9453 474f A247 Fceb50497ae8 05)
Paroxetine 10 mg film-coated tablets label from Zydus Pharmaceuticals USA Inc. The label includes the NDC 68382-097-05, packaging information for 500 tablets, and a pharmacist instruction to dispense the medication guide separately. Storage and dispensing instructions, manufacturer and distributor details, and patient safety warnings are also present.*
FDA Label Image

20 mg (1000s counts)

20 mg (1000s counts)
Paroxetine Tablets USP 20 mg film-coated tablets label. The package contains 1,000 tablets for oral use. It is labeled by Zydus Pharmaceuticals USA Inc. The label includes storage instructions (20°C to 25°C), dispensing warnings, and directions to provide a medication guide to patients. The manufacturer is Zydus Lifesciences Ltd., India, and distribution is by Zydus Pharmaceuticals USA Inc.*
FDA Label Image

30 mg (1000s count)

30 mg (1000s count)
Paroxetine Tablets, USP 30 mg film-coated tablets label showing the product name, strength, and dosage form. The label includes storage instructions, safety warnings, and the manufacturer information for Zydus Pharmaceuticals USA Inc. The package contains 1,000 tablets and is marked Rx only. The NDC number 68382-099-10 is visible.*
FDA Label Image

40 mg (30s count)

40 mg (30s count)
Paroxetine Tablets USP 40 mg film-coated oral tablets by Zydus Pharmaceuticals USA Inc. The label indicates a package of 30 tablets for prescription use only. The label includes storage instructions, child-resistant packaging notice, and manufacturer information for Zydus Lifesciences Ltd and Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.